Gender Differences in the Treatment of Ischemic Heart Disease

Author(s): Marcin Barylski, Dimitri P. Mikhailidis, Maciej Ciebiada, Jacek Rysz, Maciej Banach.

Journal Name: Current Pharmaceutical Design

Volume 17 , Issue 11 , 2011

Become EABM
Become Reviewer

Abstract:

Ischemic heart disease (IHD) is a leading cause of mortality and morbidity in most developed countries. Many studies revealed gender differences in the presentation, prevalence, and clinical outcomes of IHD. Compared with females, ST-segment elevation myocardial infarction is more often diagnosed in men. They also have a higher prevalence of IHD. These findings indicate that gender may have an important influence on IHD. Appropriate prevention, rapid diagnosis, and optimal treatment may essentially improve the care of all patients. It is therefore necessary to take into account gender differences in the features of IHD between males and females.

Keywords: Ischemic heart disease, gender difference, risk factor, treatment, cardiomyopathy, calcification, placental, Asymptomatic, atheroma, vasculitides, menopause, catecholamine, electrocardiogram, echocardiography, radioisotope, Tomography, luminal, plasminogen

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 17
ISSUE: 11
Year: 2011
Page: [1059 - 1069]
Pages: 11
DOI: 10.2174/138161211795656936
Price: $58

Article Metrics

PDF: 3